Patent · US Active

PSMA imaging agents

US10894807B2 · kind B2 · utility

0Cited by
0References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 9, 2018
Grant dateJan 19, 2021
Priority date
Expiry dateMay 9, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.